by defeatmsa | Jun 30, 2021 | Medical Research
Defeat MSA Alliance Board of Directors is pleased to report some good news from Alterity Therapeutics on ATH434, a new drug being developed by the company for the treatment of Multiple System Atrophy. “Alterity is on track to launch the Phase 2 trial of...
by defeatmsa | Jun 11, 2021 | Advocacy Blog, Advocate's Blog
JUNE 11, 2021 FOR IMMEDIATE RELEASE: Defeat MSA Alliance and MSA United International Consortium is pleased to announce the publication of “The Truly Fantastic Adventures of the MSA Warriors” – America’s first illustrated storybook about our...
by defeatmsa | Jun 11, 2021 | Medical Research
JUNE 1, 2021 Defeat MSA Alliance Research Program Advisors: Important Questions & Answers from Biohaven RE: Clinical Trial on Verdiperstat Can I still join the trial? Answer: Enrollment for the phase 3 study closed in July of 2020. When are we expected...
English
Afrikaans
Albanian
Amharic
Arabic
Armenian
Azerbaijani
Basque
Belarusian
Bengali
Bosnian
Bulgarian
Catalan
Cebuano
Chichewa
Chinese (Simplified)
Chinese (Traditional)
Corsican
Croatian
Czech
Danish
Dutch
Esperanto
Estonian
Filipino
Finnish
French
Frisian
Galician
Georgian
German
Greek
Gujarati
Haitian Creole
Hausa
Hawaiian
Hebrew
Hindi
Hmong
Hungarian
Icelandic
Igbo
Indonesian
Irish
Italian
Japanese
Javanese
Kannada
Kazakh
Khmer
Korean
Kurdish (Kurmanji)
Kyrgyz
Lao
Latin
Latvian
Lithuanian
Luxembourgish
Macedonian
Malagasy
Malay
Malayalam
Maltese
Maori
Marathi
Mongolian
Myanmar (Burmese)
Nepali
Norwegian
Pashto
Persian
Polish
Portuguese
Punjabi
Romanian
Russian
Samoan
Scottish Gaelic
Serbian
Sesotho
Shona
Sindhi
Sinhala
Slovak
Slovenian
Somali
Spanish
Sudanese
Swahili
Swedish
Tajik
Tamil
Telugu
Thai
Turkish
Ukrainian
Urdu
Uzbek
Vietnamese
Welsh
Xhosa
Yiddish
Yoruba
Zulu
Recent Comments